title: Assessment of nutritional, clinical, and immunologic status of HIV-infected, inner-city patients with multiple risk factors.
abstract: OBJECTIVE
  To evaluate the nutritional, clinical, and immunologic factors associated with human immunodeficiency virus (HIV)-infected, inner-city patients with multiple risk factors.
  
  
  METHODS
  Prospective cross-sectional nutrition evaluation of patients with HIV infection.
  
  
  METHODS
  Patients were interviewed at the outpatient clinic at Mt Sinai Medical Center, New York City, NY.
  
  
  METHODS
  Our subjects were men and women older than 18 years of age and at all stages of HIV infection (n = 56).
  
  
  METHODS
  Anthropometric measurements, history of weight changes (maintenance of preillness body weight or decrease from preillness weight status), 3-day food records, and clinical laboratory tests.
  
  
  METHODS
  Tests were used to compare patients who were at a stable weight with patients who had lost weight with regard to the anthropometric, dietary, and clinical variables. Spearman's rank correlation coefficient and chi 2 tests were applied to examine correlations between pairs and differences in proportions, respectively.
  
  
  RESULTS
  Patients were classified into groups according to whether they were at a stable weight (n = 25) or had lost weight (n = 31). All anthropometric measurements, CD4 lymphocytes, and CD8 lymphocytes were significantly lower in the patients who had lost weight. No differences were observed between the groups for absolute lymphocyte count or transferrin, hemoglobin, and albumin levels. The mean energy intake of the 56 patients was 74% of the Recommended Dietary Allowance (RDA). Forty-seven patients (84%) took vitamin and/or mineral supplements within a range of 2% to 50,000% of the RDA. No significant positive correlations were observed between nutrient intake, CD4 cells, and absolute lymphocyte count.
  
  
  CONCLUSIONS
  All anthropometric measurements, CD4 lymphocytes, and CD8 lymphocytes were notably lower in patients with weight loss. The mean energy intake of the subjects was only 74% of the RDA. Megadoses of vitamin supplements were taken by a large number of patients, but no significant positive effects were observed for absolute lymphocyte count and CD4 cells. Although supplementation of micronutrients may influence the progression of HIV infection, a balanced, nutritious diet may be more beneficial in maintaining or improving the physiologic status of the patients. However, members of a high-risk population may benefit less from HIV-related social services and food or nutrition resources. With the growing number of injection-drug users in the acquired immunodeficiency syndrome population, it will be essential to develop comprehensive strategies to address the interconnected needs for medical and nutrition care. Ensuring that patients have adequate meals during an extended course of treatment in the outpatient clinic or that dietitians have meals available in group settings or through home-delivery service may be the most appropriate nutrition intervention in these high-risk patients.
authors.affiliation: Department of Pediatrics, Mt Sinai School of Medicine, New York, NY 10029, USA.
authors.forename: E
authors.initials: E
authors.lastname: Luder
authors.forename: E
authors.initials: E
authors.lastname: Godfrey
authors.forename: J
authors.initials: J
authors.lastname: Godbold
authors.forename: D M
authors.initials: DM
authors.lastname: Simpson
mesh_terms: D000328:Adult; D000886:Anthropometry; D018791:CD4 Lymphocyte Count; D018414:CD8-Positive T-Lymphocytes; D003430:Cross-Sectional Studies; D004435:Eating; D005260:Female; D015483:HIV Antibodies / Q000097:blood; D015658:HIV Infections / Q000276:immunology / Q000503:physiopathology*; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D009519:New York City; D015596:Nutrition Assessment; D009752:Nutritional Status; D011204:Poverty Areas; D011446:Prospective Studies; D012307:Risk Factors; D015431:Weight Loss / Q000276:immunology
chemical_list: D015483:HIV Antibodies